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EDITORIAL COMMENTARYThe importance of longitudinal assessment of valve functionThierry Carrel, MDSee related article on pages 1921-8.Mokhles and colleagues1 have to be congratulated on
providing us in their article in this issue of the Journal of
Thoracic and Cardiovascular Surgery with a comprehen-
sive model of longitudinal analysis in more than 300
patients to assess the function of an allograft valve with
time after aortic valve replacement with homografts either
in the subcoronary technique or as a full root replacement.
The report is seductive: the goals of the article are to
propose a method to predict the performance of allograft
valves through the years and to identify the most significant
clinical and echocardiographic predictive factors for
adverse outcome.
In fact, Mokhles and colleagues1 are convincing that
there is no well-established method for continuous heart
valve function assessment. A statistical technique was
therefore applied to depict the prevalence of various allo-
graft valve dysfunctions (regurgitation, increased transvalv-
ular pressure gradient) versus time on the basis of numerous
echocardiographic recordings. As a pioneer in this field, a
senior member of the group, Blackstone, described as early
as 1986 a method to decompose hazard into biologically
meaningful hazard phases: early, constant, and late.2 Each
of these hazard phases is modulated by separate groups of
risk factors depending on the interval after the surgical pro-
cedure. More recently, the same group3 perfected the adap-
tation of temporal decomposition methodology to
longitudinal continuous outcome, like that used in their cur-
rent report.
Before commenting on this approach, here are just a
few words on the general findings of this article. First,
the early mortality of 5.9% was quite high for aortic
valve (or root) replacement in a younger collection of pa-
tients (with a mean age of 46 years). Because some of
these patients may have represented complex cases, it
would have been helpful to compare the results of
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evaluate better whether this mortality was acceptable.
As a second main finding, the survivals of 78% at 10
years and 65% at 15 years, as well as the reoperation-
free survival, were surprisingly poor in this report.
Mokhles and colleagues1 found that subcoronary implan-
tation was associated with a higher postoperative inci-
dence or degree of allograft valve regurgitation. One
could speculate that some technical problems were
responsible for early postoperative allograft regurgita-
tion. If regurgitation appeared in the midterm to long-
term follow-up, however, should it be considered as a
classic allograft failure independently of the mechanisms
of increasing aortic regurgitation? Another interesting
finding was that aortic diameter decreased with time,
which means that homografts were shrinking. In this
sense, some information about calcifications of the wall
of the allograft when used in the miniroot technique
would have been helpful, because this is one of the major
challenges during reoperation.
When the dynamic of the allograft valve degeneration is
considered, it would be interesting to know what Mokhles
and colleagues consider to be the ideal interval to perform
echocardiographic follow-up in these patients. Personally,
I would expect that an interval of 2 years should be
reasonable.
The results presented in this report confirm the fact that
allograft durability is comparable to that of other biologic
valve substitutes. For this reason, application of allografts
should mainly be reserved for patients with complex car-
diac or root pathologies and in the setting of endocarditis.
Male sex was found to be significantly correlated with
higher aortic gradient; Mokhles and colleagues1 speculated
about immunologic reaction, but in fact it would also have
been very interesting to assess the ABO compatibility of
the allograft (ABO match or mismatch), because some
groups have found significantly worse results when
ABO-incompatible allografts (donor to recipient) were
used.
Finally, I believe that advanced longitudinal data
analysis is really helpful to predict the behavior of the
allograft with time, and this type of information should
be available for every biologic valve substitute. Contin-
uous heart valve function, rather than valve function at
certain periods after valve replacement, would help
because valve failure is a continuous process and not
a hard end point. This piece of information would be
extremely helpful to justify the optimal choice of the
valve substitute. Nowadays, registries or retrospectivediovascular Surgery c Volume 148, Number 5 1929
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ners, but the scientific power of such studies is by far
not always convincing. What we need to allow a proper
discussion with our patients on the choice of a valvular
substitute is the detailed durability of biologic valves.
In that sense, it remains a hope that reports such as
that of Mokhles and colleagues1 will open the door to
similar analyses on other (if not all) biologic valve
prostheses.1930 The Journal of Thoracic and Cardiovascular SurReferences
1. Mokhles MM, Rajeswaran J, Bekkers JA, Borsboom GJ, Roos-Hesselink JW,
Steyerberg EW, et al. Capturing echocardiographic allograft valve function over
time after allograft aortic valve or root replacement. J Thorac Cardiovasc Surg.
2014;148:1921-8.
2. Blackstone EH, Naftel DC, Turner ME. The decomposition of time-varying haz-
ard into phases, each incorporating a separate stream of concomitant informations.
J Am Stat Assoc. 1986;81:615-25.
3. Mason DP, Rajeswaran J, Murthy SC, McNeill AM, Budev MM, Mehta AC, et al.
Spirometry after transplantation: how much better are two lungs than one? Ann
Thorac Surg. 2008;85:1193-201.gery c November 2014
